SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-008052
Filing Date
2022-03-01
Accepted
2022-03-01 16:21:07
Documents
14
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K annx-8k_20220301.htm   iXBRL 8-K 39856
2 EX-99.1 annx-ex991_6.htm EX-99.1 292087
3 GRAPHIC gszea3cw4iba000001.jpg GRAPHIC 86282
  Complete submission text file 0001564590-22-008052.txt   597138

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA annx-20220301.xsd EX-101.SCH 5677
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20220301_lab.xml EX-101.LAB 20087
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20220301_pre.xml EX-101.PRE 11935
8 EXTRACTED XBRL INSTANCE DOCUMENT annx-8k_20220301_htm.xml XML 3680
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39402 | Film No.: 22698363
SIC: 2834 Pharmaceutical Preparations